Research

Together, we aim to push boundaries further and expedite the discovery of impactful cancer cures

387
14,420
$ 70 million
57
30 years

The Kids’ Cancer Project Research Focuses

TKCP_ICON_Magnifying_Glass_RGB-ai.png

Discover

Hypothesis driven, innovative basic (T0-discovery) research that will improve our understanding of the underlying mechanisms of childhood cancer and identify novel, safe and effective new treatment strategies and technologies that will have the potential to translate to patient benefit in the clinic.

TKCP_ICON_Microscope_RGB-ai.png

Translate

High-quality clinical research (T1-T4) programs and processes that are informed by discovery research, will directly translate to a patient benefit and facilitate equal access to clinical care resulting in a positive impact on survival rates and quality of life for all children with cancer.

TKCP_ICON_Bear_and_Heart_RGB-ai.png

Support

Research programs and services aimed at enhancing cancer care by managing long-term effects, reducing side effects, improving service delivery, and engaging patients. Implementing these improvements in standard care will provide sustainable and improved care for cancer survivors.

TKCP_ICON_Community_RGB-ai.png

Build

Build resources, infrastructure and research tool kits that will facilitate high quality research and future proof the childhood cancer research landscape. Build networks and partnerships to increase funding capacity, shape policy/process and increase awareness and support from government agencies, industry, philanthropic partners and the community.

Proudly funding

Research Advisory Committee

Identifying the projects that will pursue new ideas to make a real difference sooner.

Our expert Research Advisory Committee (RAC) independently review and rate all grant submissions. Their recommendations are handed to The Kids’ Cancer Project Board who ultimately determine the studies funded. The rules of the peer review process prohibit RAC members endorsing their own projects.

Dr Timothy P Cripe

Dr Timothy P Cripe

MD, PhD

Dr Cripe is a paediatric expert at Nationwide Children’s Hospital in Columbus, Ohio. His clinical interests include gene and viral therapies for solid tumours in children, including brain tumours, neuroblastoma, and bone and soft tissue sarcomas. Dr Cripe’s research focuses on developing and testing new, targeted therapies for paediatric solid tumours and translating those findings into clinical studies.

Professor Murray Norris

Professor Murray Norris

AM BSc ANU, MAppSc NSWIT, PhD UNSW

Professor Norris was one of the first three scientists to staff the Children’s Cancer Institute when its research laboratories opened in 1984. He is Head of the Molecular Diagnostics Program and was appointed Deputy Director of Children’s Cancer Institute in 2000. He is also inaugural Director of the UNSW Centre for Childhood Cancer Research.

Dr Brenda Weigel

Dr Brenda Weigel

MD, MSc

Dr Weigel is Director of the Division of Pediatric Haematology/Oncology at Masonic Cancer Centre, University of Minnesota (U of M). She is a professor cross-appointed at U of M’s Cancer Centre and the Department of Pediatrics, and the recipient of the Lehman/Children’s Cancer Research Fund Endowed Chair in Pediatric Cancer. She is also Chair of Developmental Therapeutics for the Children’s Oncology Group.

Professor Jonathan G Izant

Professor Jonathan G Izant

PhD

Professor Izant has extensive international experience in biomedical research, business and non-profit leadership at Yale School of Medicine, Garvan Institute, QUT, Johnson & Johnson and the Bill & Melinda Gates Foundation. He has helped create biotech, bioinformatics and business development companies, was a member of the NHMRC Human Gene Advisory Panel and has served on numerous government and private research funding committees.

Associate Professor Andrew Moore

Associate Professor Andrew Moore

MBBS, FRACP, PhD

Associate Professor Moore is Senior Staff Specialist, Paediatric Oncology at Queensland Children’s Hospital where he is also Director, Clinical and Biomedical Research. He specialises in childhood leukaemia, with special interest in acute myeloid leukaemia (AML). Associate Professor Moore is and an academic title holder with The University of Queensland’s Faculty of Medicine and is Director of the Queensland Children's Tumour Bank.

Dr Justine Stehn

Dr Justine Stehn

PhD

Dr Stehn is the Integrative Oncology and Supportive Care Research Manager at Chris O’Brien Lifehouse Comprehensive Cancer hospital. She has over 25 years’ experience in the academic and industry health sectors working on translational and clinical research programs in both childhood and adult cancers. Her expertise is in the building of research programs that support the implementation of new treatment strategies that improve both the quality and quantity of life of people with cancer.

Associate Professor David Ziegler

Associate Professor David Ziegler

MBBS UNSW, MD/PhD UNSW, Dip Paed, FRACP (Chair)

Associate Professor Ziegler is a senior Staff Specialist in the Kids Cancer Centre at Sydney Children’s Hospital, Randwick. He is a paediatric oncologist with expertise in neuro-oncology and early phase clinical trials. He has concurrent appointments as Group Leader at the Children’s Cancer Institute, and conjoint Associate Professor at the University of New South Wales.

Dr Jordana McLoone

Dr Jordana McLoone

Dr McLoone is a senior research fellow within the Behavioural Sciences Unit, Australia's largest paediatric psycho-oncology research group, which straddles the School of Clinical Medicine, UNSW Sydney and the Kids Cancer Centre, Sydney Children's Hospital. Beyond her extensive research into the psychosocial impact of childhood cancer, she also sits on two ANZCHOG committees as well as the COSA Financial Toxicity Working Group, is involved in international childhood cancer initiatives in Papua New Guinea and Oceania, teaches both undergraduate and higher degree research students and has a special interest in artificial intelligence and innovations in telehealth.


Col Reynolds Fellowships

 The Col Reynolds Fellowships seek to encourage talented young researchers by supporting PhD students, early and mid-career researchers and young clinicians. 
 


The Kids’ Cancer Project Grants

The Kids’ Cancer Project supports scientific studies that will have the greatest chance of clinical success in the improvement of treatments for childhood cancers. 
 

TKCP-Research-advisory-committee-RAC-funding-2018.jpg

Our vision is to see a one hundred per cent survival rate for children with cancer while eradicating the harmful impacts treatment can bring. The Kids’ Cancer Project - with the generous and dedicated help of our supporters like you - will keep going until we've achieved that.

Get Involved or Donate

Latest Research News

Support innovative research that will lead to discoveries that will improve the understanding of underlying mechanism of disease and identify novel, safe and effective new treatments. See some of these inspiring projects below.

2023 Fellowship successful applicants

Top Of Page